Stocktoria
PROKIDNEY CORP. PROK
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-06-30
PROKIDNEY CORP. statistics & valuation
Market cap$552.8M
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -18477.8% | -241678.9% | — | — | — |
| Net margin | -7725.2% | -80507.9% | — | — | — |
| FCF margin | -15152.6% | -205078.9% | — | — | — |
| Return on assets | -20.6% | -13.9% | -8.4% | — | -136.8% |
| Return on equity | 6.8% | 6.1% | 3.2% | — | -204.9% |
| Current ratio | 9.13 | 10.93 | 14.94 | 46.42 | 2.21 |
| Revenue growth | 1075.0% | — | — | — | — |
Source: SEC EDGAR filings · CIK 0001850270 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.